3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
31
Prostatic Neoplasms
17
Breast Neoplasms
8
Sarcoma
6
Vaginal Neoplasms
4
Neoplasms
4
Endometrial Neoplasms
4
Vulvar Neoplasms
3
Uterine Neoplasms
3
Lung Neoplasms
3
Carcinoma, Ductal, Breast
3
Radiation Injuries
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Gliosarcoma
2
Glioblastoma
2
Esophageal Neoplasms
2
Desmoplastic Small Round Cell Tumor
2
Central Nervous System Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
Breast Carcinoma In Situ
2
Anemia
2
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Retinoblastoma
1
Recurrent Head and Neck Carcinoma
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Interventions
Cisplatin
2
durvalumab
1
atezolizumab
1
Radiotherapy
1
Carboplatin
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Locally Advanced Cervical Cancer
×
Brachytherapy
×
Clear all
NCT03830866
2024-07-26
CALLA
AstraZeneca
Phase 3
Completed
770 enrolled
12 charts